Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2022 Publisher: Besins Healthcare (UK) Ltd, Lion Court, 25 Procter Street, Holborn, London, WC1V 6NY, United Kingdom
IMVAGGIS 0.03 mg pessary.
Pharmaceutical Form |
---|
Pessary. White, homogenous pessaries. |
1 pessary contains 0.03 mg estriol.
Excipient with known effect: Each pessary contains a maximum of 0.008 mg butylhydroxytoluene.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Estriol |
Estriol is a steroid, a weak estrogen, specifically an agonist of the estrogen receptors ERα and ERβ. It is one of three major endogenous estrogens, the others being estradiol and estrone. |
List of Excipients |
---|
Butylhydroxytoluene |
Aluminium/laminated PE strips with pessaries packed in a cardboard carton.
Pack sizes with 10, 15, 20, 24 and 30 pessaries.
Not all pack sizes may be marketed.
Besins Healthcare (UK) Ltd, Lion Court, 25 Procter Street, Holborn, London, WC1V 6NY, United Kingdom
PL 42714/0001
15/03/2018
Drug | Countries | |
---|---|---|
IMVAGGIS | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.